We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

81 hedge funds and large institutions have $414M invested in Repros Therapeutics Inc. in 2013 Q2 according to their latest regulatory filings, with 81 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

23% less call options, than puts

Call options by funds: $35.1M | Put options by funds: $45.3M

Holders
81
Holders Change
+81
Holders Change %
–
% of All Funds
2.64%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
81
Increased
–
Reduced
–
Closed
–
Calls
$35.1M
Puts
$45.3M
Net Calls
-$10.2M
Net Calls Change
-$10.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
51
Invesco
Georgia
$481K +$460K +26,063 New
TA
52
Teachers Advisors
New York
$480K +$460K +26,036 New
Swiss National Bank
53
Swiss National Bank
Switzerland
$393K +$376K +21,300 New
Morgan Stanley
54
Morgan Stanley
New York
$376K +$360K +20,384 New
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$324K +$310K +17,562 New
MLICM
56
Metropolitan Life Insurance Company (MetLife)
New York
$296K +$284K +16,053 New
VOYA Investment Management
57
VOYA Investment Management
Georgia
$264K +$253K +14,308 New
T
58
TradeWorx
New Jersey
$261K +$250K +14,138 New
NFA
59
Nationwide Fund Advisors
Ohio
$261K +$250K +14,152 New
Manulife (Manufacturers Life Insurance)
60
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$255K +$244K +13,800 New
WAM
61
Wolverine Asset Management
Illinois
$250K +$240K +13,600 New
SIP
62
Stoneridge Investment Partners
Pennsylvania
$247K +$236K +13,377 New
AIG
63
American International Group
New York
$237K +$227K +12,841 New
ProShare Advisors
64
ProShare Advisors
Maryland
$224K +$214K +12,138 New
RJFSA
65
Raymond James Financial Services Advisors
Florida
$212K +$203K +11,500 New
BA
66
BlackRock Advisors
Delaware
$210K +$201K +11,374 New
State Board of Administration of Florida Retirement System
67
State Board of Administration of Florida Retirement System
Florida
$203K +$194K +10,988 New
U
68
UBS
Switzerland
$198K +$190K +10,753 New
JG
69
Jefferies Group
New York
$89K +$85K +4,815 New
PCM
70
Prelude Capital Management
New York
$79K +$75.9K +4,300 New
NTCOC
71
Northern Trust Company of Connecticut
Connecticut
$76K +$73K +4,136 New
Bessemer Group
72
Bessemer Group
New Jersey
$31K +$29.9K +1,691 New
SCA
73
SAC Capital Advisors
Connecticut
$26K +$24.7K +1,400 New
Teacher Retirement System of Texas
74
Teacher Retirement System of Texas
Texas
$23K +$22.4K +1,270 New
Ameriprise
75
Ameriprise
Minnesota
$22K +$21.1K +1,192 New
1 2
3
4

RPRX Hedge Fund Activity: Q2 2013 in Review

81 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q2 2013, worth a combined $414M.

Buyers outnumbered sellers: 81 funds opened new RPRX positions and 0 closed out — a net gain of 81 holders — while 0 added to existing stakes and 0 trimmed.

  • 81 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $414M of Repros Therapeutics Inc. stock for Q2 2013.
  • 81 funds opened new Repros Therapeutics Inc. positions in Q2 2013 and 0 closed out, a net change of +81 holders.

Based on aggregated 13F filings for Q2 2013.